Recently, there has been promise in the realm of immunotherapy and targeted therapies, including immune inhibitors targeting PD-L1, which demonstrate potential in enhancing the prognosis for individuals with unstable microsatellite cancer [4]. The gene discussed is CD274; the disease is cancer.